BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Auberger J, Lass-Flörl C, Ulmer H, Nogler-Semenitz E, Clausen J, Gunsilius E, Einsele H, Gastl G, Nachbaur D. Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol 2008;88:508-15. [PMID: 18982251 DOI: 10.1007/s12185-008-0184-2] [Cited by in Crossref: 67] [Cited by in F6Publishing: 55] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 So W, Pandya S, Quilitz R, Shah B, Greene JN. Infectious Risks and Complications in Adult Leukemic Patients Receiving Blinatumomab. Mediterr J Hematol Infect Dis 2018;10:e2018029. [PMID: 29755706 DOI: 10.4084/MJHID.2018.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
2 Paige E, Haywood P, Xie M, Worth L, Thursky K, Urbancic K, Bajel A, Slavin M. Auditing fungal disease in leukemia patients in a tertiary care center: opportunities and challenges for an antifungal stewardship program. Leuk Lymphoma 2019;60:2373-83. [PMID: 31096813 DOI: 10.1080/10428194.2019.1590570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Baddley JW, Stephens JM, Ji X, Gao X, Schlamm HT, Tarallo M. Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes. BMC Infect Dis 2013;13:29. [PMID: 23343366 DOI: 10.1186/1471-2334-13-29] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 9.9] [Reference Citation Analysis]
4 Young AY, Leiva Juarez MM, Evans SE. Fungal Pneumonia in Patients with Hematologic Malignancy and Hematopoietic Stem Cell Transplantation. Clin Chest Med 2017;38:479-91. [PMID: 28797490 DOI: 10.1016/j.ccm.2017.04.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
5 Tavakoli M, Yazdani Charati J, Hedayati MT, Moosazadeh M, Badiee P, Seyedmousavi S, Denning DW. National trends in incidence, prevalence and disability-adjusted life years of invasive aspergillosis in Iran: a systematic review and meta-analysis. Expert Rev Respir Med 2019;13:1121-34. [PMID: 31426666 DOI: 10.1080/17476348.2019.1657835] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Yilmaz M, Mete B, Ozaras R, Kaynak G, Tabak F, Tenekecioğlu Y, Oztürk R. Aspergillus fumigatus infection as a delayed manifestation of prosthetic knee arthroplasty and a review of the literature. Scand J Infect Dis 2011;43:573-8. [PMID: 21526903 DOI: 10.3109/00365548.2011.574294] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
7 Golmia R, Bello I, Marra A, Hamerschlak N, Osawa A, Scheinberg M. Aspergillus fumigatus joint infection: a review. Semin Arthritis Rheum 2011;40:580-4. [PMID: 20843541 DOI: 10.1016/j.semarthrit.2010.07.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
8 Li Y, Xu W, Jiang Z, Gao Y, Pang Y, Li L, OuYang L, Zhang L, Liu Z, Wang Y, Xiao Y, Huang X. Neutropenia and invasive fungal infection in patients with hematological malignancies treated with chemotherapy: a multicenter, prospective, non-interventional study in China. Tumour Biol 2014;35:5869-76. [PMID: 24664582 DOI: 10.1007/s13277-014-1777-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
9 Neofytos D, Lu K, Hatfield-Seung A, Blackford A, Marr KA, Treadway S, Ostrander D, Nussenblatt V, Karp J. Epidemiology, outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy. Diagn Microbiol Infect Dis 2013;75:144-9. [PMID: 23142166 DOI: 10.1016/j.diagmicrobio.2012.10.001] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 5.7] [Reference Citation Analysis]
10 García-Suárez J, Gómez-Herruz P, Cuadros JA, Burgaleta C. Epidemiology and outcome of Rhodotorula infection in haematological patients. Mycoses 2011;54:318-24. [PMID: 20337934 DOI: 10.1111/j.1439-0507.2010.01868.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
11 Biehl LM, Vehreschild JJ, Liss B, Franke B, Markiefka B, Persigehl T, Bücker V, Wisplinghoff H, Scheid C, Cornely OA, Vehreschild MJGT. A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis. J Antimicrob Chemother 2016;71:2634-41. [DOI: 10.1093/jac/dkw199] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
12 Hsu LY, Lee DG, Yeh SP, Bhurani D, Khanh BQ, Low CY, Norasetthada L, Chan T, Kwong YL, Vaid AK, Alejandria I, Mendoza M, Chen CY, Johnson A, Tan TY. Epidemiology of invasive fungal diseases among patients with haematological disorders in the Asia-Pacific: a prospective observational study. Clin Microbiol Infect 2015;21:594.e7-11. [PMID: 25749561 DOI: 10.1016/j.cmi.2015.02.019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
13 Hardak E, Fuchs E, Geffen Y, Zuckerman T, Oren I. Clinical Spectrum, Diagnosis and Outcome of Rare Fungal Infections in Patients with Hematological Malignancies: Experience of 15-Year Period from a Single Tertiary Medical Center. Mycopathologia. 2020;185:347-355. [PMID: 32100219 DOI: 10.1007/s11046-020-00436-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Peterson L, Ostermann J, Rieger H, Ostermann H, Rieger CT. Posaconazole prophylaxis - impact on incidence of invasive fungal disease and antifungal treatment in haematological patients. Mycoses 2013;56:651-8. [DOI: 10.1111/myc.12086] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
15 Fischer M, Müller JP, Spies-Weisshart B, Gräfe C, Kurzai O, Hünniger K, Hochhaus A, Scholl S, Schnetzke U. Isoform localization of Dectin-1 regulates the signaling quality of anti-fungal immunity. Eur J Immunol 2017;47:848-59. [PMID: 28303575 DOI: 10.1002/eji.201646849] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
16 Han SB, Kim SK, Lee JW, Yoon JS, Chung NG, Cho B, Jeong DC, Kang JH, Kim HK, Lee DG, Lee HS, Im SA. Serum galactomannan index for early prediction of mortality in immunocompromised children with invasive pulmonary aspergillosis. BMC Infect Dis 2015;15:271. [PMID: 26168914 DOI: 10.1186/s12879-015-1014-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
17 Hites M, Goicoechea Turcott EW, Taccone FS. The role of galactomannan testing to diagnose invasive pulmonary aspergillosis in critically ill patients. Ann Transl Med 2016;4:353. [PMID: 27761457 DOI: 10.21037/atm.2016.08.32] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
18 Hansen BA, Wendelbo Ø, Bruserud Ø, Hemsing AL, Mosevoll KA, Reikvam H. Febrile Neutropenia in Acute Leukemia. Epidemiology, Etiology, Pathophysiology and Treatment. Mediterr J Hematol Infect Dis 2020;12:e2020009. [PMID: 31934319 DOI: 10.4084/MJHID.2020.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
19 Gedik H, Şimşek F, Yıldırmak T, Kantürk A, Arıca D, Aydın D, Demirel N, Yokuş O. Novel antifungal drugs against fungal pathogens: do they provide promising results for treatment? Indian J Hematol Blood Transfus 2015;31:196-205. [PMID: 25825558 DOI: 10.1007/s12288-014-0370-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Vaughan C, Bartolo A, Vallabh N, Leong SC. A meta-analysis of survival factors in rhino-orbital-cerebral mucormycosis-has anything changed in the past 20 years? Clin Otolaryngol 2018;43:1454-64. [PMID: 29947167 DOI: 10.1111/coa.13175] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
21 Prattes J, Heldt S, Eigl S, Hoenigl M. Point of Care Testing for the Diagnosis of Fungal Infections: Are We There Yet? Curr Fungal Infect Rep 2016;10:43-50. [PMID: 27358661 DOI: 10.1007/s12281-016-0254-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
22 Taccone FS, Van den Abeele AM, Bulpa P, Misset B, Meersseman W, Cardoso T, Paiva JA, Blasco-Navalpotro M, De Laere E, Dimopoulos G, Rello J, Vogelaers D, Blot SI; AspICU Study Investigators. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes. Crit Care 2015;19:7. [PMID: 25928694 DOI: 10.1186/s13054-014-0722-7] [Cited by in Crossref: 191] [Cited by in F6Publishing: 155] [Article Influence: 31.8] [Reference Citation Analysis]
23 Janssen A, van der Bruggen T, Haas PJ, de Jong PA, Minnema MC. Comparison of the occurrence of mold infection among patients receiving chemotherapy for acute leukemia versus patients undergoing stem cell transplantation. Eur J Haematol 2011;87:419-25. [PMID: 21732981 DOI: 10.1111/j.1600-0609.2011.01678.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Vu CTB, Thammahong A, Yagita H, Azuma M, Hirankarn N, Ritprajak P, Leelahavanichkul A. Blockade Of PD-1 Attenuated Postsepsis Aspergillosis Via The Activation of IFN-γ and The Dampening of IL-10. Shock 2020;53:514-24. [PMID: 31306346 DOI: 10.1097/SHK.0000000000001392] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
25 Fites JS, Gui M, Kernien JF, Negoro P, Dagher Z, Sykes DB, Nett JE, Mansour MK, Klein BS. An unappreciated role for neutrophil-DC hybrids in immunity to invasive fungal infections. PLoS Pathog 2018;14:e1007073. [PMID: 29782541 DOI: 10.1371/journal.ppat.1007073] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
26 Salehi E, Hedayati MT, Zoll J, Rafati H, Ghasemi M, Doroudinia A, Abastabar M, Tolooe A, Snelders E, van der Lee HA, Rijs AJ, Verweij PE, Seyedmousavi S, Melchers WJ. Discrimination of Aspergillosis, Mucormycosis, Fusariosis, and Scedosporiosis in Formalin-Fixed Paraffin-Embedded Tissue Specimens by Use of Multiple Real-Time Quantitative PCR Assays. J Clin Microbiol 2016;54:2798-803. [PMID: 27605714 DOI: 10.1128/JCM.01185-16] [Cited by in Crossref: 44] [Cited by in F6Publishing: 17] [Article Influence: 8.8] [Reference Citation Analysis]
27 Lass-Flörl C, Dietl AM, Kontoyiannis DP, Brock M. Aspergillus terreus Species Complex. Clin Microbiol Rev 2021;:e0031120. [PMID: 34190571 DOI: 10.1128/CMR.00311-20] [Reference Citation Analysis]
28 Hahn-Ast C, Glasmacher A, Mückter S, Schmitz A, Kraemer A, Marklein G, Brossart P, von Lilienfeld-Toal M. Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006. J Antimicrob Chemother 2010;65:761-8. [PMID: 20106864 DOI: 10.1093/jac/dkp507] [Cited by in Crossref: 60] [Cited by in F6Publishing: 45] [Article Influence: 5.5] [Reference Citation Analysis]
29 Quindós G. Candidiasis, aspergilosis y otras micosis invasoras en receptores de trasplantes de órgano sólido. Revista Iberoamericana de Micología 2011;28:110-9. [DOI: 10.1016/j.riam.2011.06.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
30 Slesiona S, Ibrahim-Granet O, Olias P, Brock M, Jacobsen ID. Murine infection models for Aspergillus terreus pulmonary aspergillosis reveal long-term persistence of conidia and liver degeneration. J Infect Dis 2012;205:1268-77. [PMID: 22438397 DOI: 10.1093/infdis/jis193] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
31 Shao L, Jiang L, Wu S, Yu L, Wang L, Huang X. Simultaneous occurrence of invasive pulmonary aspergillosis and diffuse large B-cell lymphoma: case report and literature review. BMC Cancer 2020;20:15. [PMID: 31906982 DOI: 10.1186/s12885-019-6471-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Feng Y, Guo W, Wang Y, Shi W, Liu C, Li D, Qiu Y, Shi D. Rhinocerebral mucormycosis caused by Rhizopus oryzae in a patient with acute myeloid leukemia: A case report. WJD 2020;8:1-9. [DOI: 10.5314/wjd.v8.i1.1] [Reference Citation Analysis]
33 Perkhofer S, Lass-flörl C, Hell M, Russ G, Krause R, Hönigl M, Geltner C, Auberger J, Gastl G, Mitterbauer M, Willinger B, Knöbl P, Resch G, Waldner R, Makrai A, Hartmann G, Girschikofsky M, Greil R. The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. International Journal of Antimicrobial Agents 2010;36:531-6. [DOI: 10.1016/j.ijantimicag.2010.08.010] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 7.1] [Reference Citation Analysis]
34 Gomez SM, Caniza M, Fynn A, Vescina C, Ruiz CD, Iglesias D, Sosa F, Sung L. Fungal infections in hematopoietic stem cell transplantation in children at a pediatric children's hospital in Argentina. Transpl Infect Dis 2018;20:e12913. [PMID: 29679436 DOI: 10.1111/tid.12913] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
35 Arabatzis M, Velegraki A. Sexual reproduction in the opportunistic human pathogen Aspergillus terreus. Mycologia 2013;105:71-9. [PMID: 23074177 DOI: 10.3852/11-426] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
36 Badiee P, Hashemizadeh Z, Ramzi M, Karimi M, Mohammadi R. Non-Invasive Methods to Diagnose Fungal Infections in Pediatric Patients with Hematologic Disorders. Jundishapur J Microbiol 2016;9:e41573. [PMID: 28138379 DOI: 10.5812/jjm.41573] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
37 Simitsopoulou M, Roilides E, Georgiadou E, Paliogianni F, Walsh TJ. Differential transcriptional profiles induced by amphotericin B formulations on human monocytes during response to hyphae of Aspergillus fumigatus. Med Mycol 2011;49:176-85. [PMID: 20807031 DOI: 10.3109/13693786.2010.510539] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
38 Rieger CT, Huppmann S, Peterson L, Rieger H, Ostermann H. Classification of invasive fungal disease in patients with acute myeloid leukaemia. Mycoses 2011;54:e92-8. [PMID: 20202112 DOI: 10.1111/j.1439-0507.2009.01850.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
39 Bhatt VR, Viola GM, Ferrajoli A. Invasive fungal infections in acute leukemia. Ther Adv Hematol 2011;2:231-47. [PMID: 23556092 DOI: 10.1177/2040620711410098] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
40 Babouee Flury B, Weisser M, Prince SS, Bubendorf L, Battegay M, Frei R, Goldenberger D. Performances of two different panfungal PCRs to detect mould DNA in formalin-fixed paraffin-embedded tissue: what are the limiting factors? BMC Infect Dis 2014;14:692. [PMID: 25518949 DOI: 10.1186/s12879-014-0692-z] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.9] [Reference Citation Analysis]
41 George B, Menon H, Bhurani D, Damodar S, Apte S, Seth T, Sharma A, Shyam R, Malhotra P, Easow J, Lakshmi KM, Agrawal N, Sengar M, Nataraj KS, Ahmed R, Sharma S, Khadwal A, Prakash G, Abraham A, Devasia A, Korula A, Mathews V. A Prospective Observational Multi-institutional Study on Invasive Fungal Infections Following Chemotherapy for Acute Myeloid Leukemia (MISFIC Study): A Real World Scenario from India. Indian J Hematol Blood Transfus 2020;36:97-103. [PMID: 32158091 DOI: 10.1007/s12288-019-01173-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Azevedo MM, Pina-Vaz C, Baltazar F. Microbes and Cancer: Friends or Faux? Int J Mol Sci 2020;21:E3115. [PMID: 32354115 DOI: 10.3390/ijms21093115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
43 Korula A, Abraham A, Abubacker FN, Viswabandya A, Lakshmi KM, Abraham OC, Rupali P, Varghese GM, Michael JS, Srivastava A, Mathews V, George B. Invasive fungal infection following chemotherapy for acute myeloid leukaemia-Experience from a developing country. Mycoses 2017;60:686-91. [PMID: 28736936 DOI: 10.1111/myc.12646] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
44 Angarone M. Fungal Infections in Cancer Patients. In: Stosor V, Zembower TR, editors. Infectious Complications in Cancer Patients. Cham: Springer International Publishing; 2014. pp. 129-55. [DOI: 10.1007/978-3-319-04220-6_4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
45 Song A, Yang D, Huang Y, Jiang E, Yan Z, Wei J, Wang M, Ma Q, He Y, Zhang R, Zhai W, Feng S, Han M. Secondary antifungal prophylaxis in hematological malignancies in a tertiary medical center. Int J Hematol 2010;92:725-31. [DOI: 10.1007/s12185-010-0723-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
46 Chien S, Liu Y, Liu C, Ko P, Wang H, Hsiao L, Chiou T, Liu J, Gau J. Invasive mold infections in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. Journal of Microbiology, Immunology and Infection 2019;52:973-82. [DOI: 10.1016/j.jmii.2018.09.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
47 Hoenigl M, Zollner-schwetz I, Sill H, Linkesch W, Lass-flörl C, Schnedl WJ, Krause R. Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies: IFIs in haematological malignancies. Mycoses 2011;54:454-9. [DOI: 10.1111/j.1439-0507.2010.01881.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
48 Hachem R, Gomes MZ, El Helou G, El Zakhem A, Kassis C, Ramos E, Jiang Y, Chaftari AM, Raad II. Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy. J Antimicrob Chemother 2014;69:3148-55. [PMID: 25006241 DOI: 10.1093/jac/dku241] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 5.1] [Reference Citation Analysis]
49 Avelino-Silva VI, Ramos JF, Leal FE, Testagrossa L, Novis YS. Disseminated Fusarium infection in autologous stem cell transplant recipient. Braz J Infect Dis 2015;19:90-3. [PMID: 25307678 DOI: 10.1016/j.bjid.2014.08.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
50 Kurosawa M, Yonezumi M, Hashino S, Tanaka J, Nishio M, Kaneda M, Ota S, Koda K, Suzuki N, Yoshida M, Hirayama Y, Takimoto R, Torimoto Y, Mori A, Takahashi T, Iizuka S, Ishida T, Kobayashi R, Oda T, Sakai H, Yamamoto S, Takahashi F, Fukuhara T. Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol 2012;96:748-57. [PMID: 23111539 DOI: 10.1007/s12185-012-1210-y] [Cited by in Crossref: 74] [Cited by in F6Publishing: 57] [Article Influence: 8.2] [Reference Citation Analysis]
51 van de Peppel RJ, von dem Borne PA, le Cessie S, de Boer MGJ. A new time-dependent approach for assessment of the impact of invasive aspergillosis shows effect on short- but not on long-term survival of patients with AML or high-risk MDS. Bone Marrow Transplant 2017;52:883-8. [PMID: 28504663 DOI: 10.1038/bmt.2017.71] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
52 Showel MM, Levis M. Advances in treating acute myeloid leukemia. F1000Prime Rep 2014;6:96. [PMID: 25374674 DOI: 10.12703/P6-96] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
53 Auberger J, Lass-florl C, Aigner M, Clausen J, Gastl G, Nachbaur D. Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study. Journal of Antimicrobial Chemotherapy 2012;67:2268-73. [DOI: 10.1093/jac/dks189] [Cited by in Crossref: 100] [Cited by in F6Publishing: 87] [Article Influence: 11.1] [Reference Citation Analysis]
54 Pham AN, Bubalo JS, Lewis JS 2nd. Comparison of posaconazole serum concentrations from haematological cancer patients on posaconazole tablet and oral suspension for treatment and prevention of invasive fungal infections. Mycoses 2016;59:226-33. [PMID: 26742659 DOI: 10.1111/myc.12452] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 7.2] [Reference Citation Analysis]
55 Blaes A, Cavert W, Morrison V. Malassezia : is it a pulmonary pathogen in the stem cell transplant population? Transplant Infectious Disease 2009;11:313-7. [DOI: 10.1111/j.1399-3062.2009.00404.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]